tiprankstipranks
Advertisement
Advertisement

PYXS Stock Latest News

Pyxis Oncology price target lowered to $8 from $9 at Stifel
The FlyPyxis Oncology price target lowered to $8 from $9 at Stifel
24d ago
PYXS
Pyxis Oncology Reports Q4 Results, Advances MICVO Program
PremiumCompany Announcements
Pyxis Oncology Reports Q4 Results, Advances MICVO Program
25d ago
8K
PYXS
PYXS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PYXS Earnings this Week: How Will it Perform?
25d ago
PYXS
Pyxis Oncology Announces Interim CEO Amid Leadership Transition
PremiumCompany Announcements
Pyxis Oncology Announces Interim CEO Amid Leadership Transition
2M ago
8K
PYXS
Pyxis Oncology appoints board member Thomas Civik as Interim CEO
PremiumThe Fly
Pyxis Oncology appoints board member Thomas Civik as Interim CEO
2M ago
PYXS
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
PremiumMarket News3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
4M ago
PYXS
RGNX
Pyxis Oncology price target lowered to $5 from $8 at RBC Capital
Premium
The Fly
Pyxis Oncology price target lowered to $5 from $8 at RBC Capital
4M ago
PYXS
Maintaining a Buy on Pyxis: Early MICVO Efficacy, Dose Optimization, and 2026 Data as the Next Major Catalyst
Premium
Ratings
Maintaining a Buy on Pyxis: Early MICVO Efficacy, Dose Optimization, and 2026 Data as the Next Major Catalyst
4M ago
PYXS
Pyxis Oncology price target raised to $7 from $5 at H.C. Wainwright
PremiumThe Fly
Pyxis Oncology price target raised to $7 from $5 at H.C. Wainwright
4M ago
PYXS
Pyxis Oncology Reports Strong MICVO Data and Financing
PremiumCompany Announcements
Pyxis Oncology Reports Strong MICVO Data and Financing
4M ago
8K
PYXS
Pyxis Oncology announces preliminary Phase 1 data for micvotabart pelidotin
PremiumThe Fly
Pyxis Oncology announces preliminary Phase 1 data for micvotabart pelidotin
4M ago
MRK
PYXS
Pyxis to present updated data from Phase 1 monotherapy study in mid-2026
PremiumThe Fly
Pyxis to present updated data from Phase 1 monotherapy study in mid-2026
4M ago
PYXS
Pyxis Oncology sees cash runway into 4Q26
PremiumThe FlyPyxis Oncology sees cash runway into 4Q26
4M ago
PYXS
Pyxis Oncology files $350M mixed securities shelf
Premium
The Fly
Pyxis Oncology files $350M mixed securities shelf
5M ago
PYXS
Pyxis Oncology price target raised to $8 from $5 at Stephens
Premium
The Fly
Pyxis Oncology price target raised to $8 from $5 at Stephens
5M ago
PYXS
Pyxis Oncology Reports Increased Losses Amid Development Focus
PremiumCompany Announcements
Pyxis Oncology Reports Increased Losses Amid Development Focus
5M ago
PYXS
Promising Efficacy of Pyxis Oncology’s MICVO in HNSCC Justifies Buy Rating Despite Financial Constraints
PremiumRatings
Promising Efficacy of Pyxis Oncology’s MICVO in HNSCC Justifies Buy Rating Despite Financial Constraints
5M ago
PYXS
Buy Rating for Pyxis Oncology: Promising Clinical Data and Strong Financial Position
PremiumRatings
Buy Rating for Pyxis Oncology: Promising Clinical Data and Strong Financial Position
5M ago
PYXS
Promising Developments in Pyxis Oncology’s MICVO Drive Buy Rating
PremiumRatings
Promising Developments in Pyxis Oncology’s MICVO Drive Buy Rating
5M ago
PYXS
Pyxis Oncology reports Q3 EPS (35c), consensus (34c)
PremiumThe FlyPyxis Oncology reports Q3 EPS (35c), consensus (34c)
5M ago
PYXS
Pyxis Oncology resumed with a Buy at Stifel
Premium
The Fly
Pyxis Oncology resumed with a Buy at Stifel
5M ago
PYXS
Pyxis Oncology’s Promising Study on PYX-201 and Pembrolizumab in Advanced Solid Tumors
Premium
Company Announcements
Pyxis Oncology’s Promising Study on PYX-201 and Pembrolizumab in Advanced Solid Tumors
6M ago
PYXS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >